BBS-Bioactive Bone Substitutes Overview

  • Founded
  • 2003
Founded
  • Status
  • Public
  • Employees
  • 16
Employees
  • Stock Symbol
  • BONEH
Stock Symbol
  • Share Price
  • $3.62
  • (As of Friday Closing)

BBS-Bioactive Bone Substitutes General Information

Description

BBS-Bioactive Bone Substitutes PLC is a health technology company, that develops, designs and manufactures innovative bioactive bone-graft substitute implants. Its ortho biological product ARTEBONE, which is based on tricalcium phosphate (TCP) and natural spectrum of bone proteins has the capability of bone regeneration.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Other Healthcare Services
Stock Exchange
HEL
Primary Office
  • Kiviharjunlenkki 6
  • 90220 Oulu
  • Finland
+358 020 0000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BBS-Bioactive Bone Substitutes Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.62 $3.63 $3.52 - $7.99 $23.8M 6.57M 6.8K -$0.52

BBS-Bioactive Bone Substitutes Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 44,985 44,985 17,861 18,107
Revenue 0 0 0
EBITDA (2,771) (2,771) (1,468) 834
Net Income (3,113) (3,113) (1,834) 448
Total Assets 15,612 15,612 11,014 12,762
Total Debt 7,395 7,395 7,089 7,242
Public Fundamental Data provided by Morningstar, Inc. disclaimer

BBS-Bioactive Bone Substitutes Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BBS-Bioactive Bone Substitutes‘s full profile, request access.

Request a free trial

BBS-Bioactive Bone Substitutes Executive Team (7)

Name Title Board Seat Contact Info
Pekka Jalovaara Chief Executive Officer & Founder
Liisa Hukka Chief Financial Officer
Hanna Tölli Ph.D Chief Operating Officer
Paul Watkins Chief Commercial Officer
You’re viewing 4 of 7 executive team members. Get the full list »

BBS-Bioactive Bone Substitutes Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BBS-Bioactive Bone Substitutes Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BBS-Bioactive Bone Substitutes‘s full profile, request access.

Request a free trial